NEW YORK (GenomeWeb) – Advaita Bioinformatics has received a notice of award from the National Institute of General Medical Sciences for a Phase II Small Business Investigational Research grant to develop and implement a new method of identifying disease subtypes and subgroups of patients within disease phenotypes.

The Plymouth, Mich.-based firm will use the three-year, $1.8 million grant also to identify biological pathway signatures for specific diseases and to identify pathway signatures for drugs in order to repurpose them, it said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: measles virus nucleocapsid structure, and more.

African and US health officials work to establish an Africa-wide Centres for Disease Control and Prevention.

Nature has retracted a 2002 epigenetics paper for image manipulation.

The World Health Organization calls for the public release of clinical trial results within a year of the completion of data collection.

May
28
Sponsored by
PerkinElmer

This online seminar will demonstrate how RNA-seq analysis in a model organism can provide insights into human disease.